OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 90 filers reported holding OLEMA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,766,264 | -3.5% | 466,904 | -29.4% | 0.00% | 0.0% |
| Q2 2023 | $5,973,119 | +39.8% | 661,475 | -46.3% | 0.00% | 0.0% |
| Q1 2023 | $4,271,973 | +39.7% | 1,231,116 | -1.4% | 0.00% | 0.0% |
| Q4 2022 | $3,057,723 | -14.0% | 1,248,050 | -3.1% | 0.00% | 0.0% |
| Q3 2022 | $3,555,000 | -43.4% | 1,288,142 | -16.5% | 0.00% | -50.0% |
| Q2 2022 | $6,280,000 | +14.2% | 1,542,915 | +19.5% | 0.00% | +100.0% |
| Q1 2022 | $5,498,000 | -59.8% | 1,290,865 | -11.8% | 0.00% | -66.7% |
| Q4 2021 | $13,692,000 | -66.4% | 1,462,812 | -1.0% | 0.00% | -62.5% |
| Q3 2021 | $40,707,000 | +1.3% | 1,477,055 | +2.8% | 0.01% | -11.1% |
| Q2 2021 | $40,193,000 | -15.6% | 1,436,479 | +0.1% | 0.01% | -25.0% |
| Q1 2021 | $47,607,000 | -31.0% | 1,434,796 | 0.0% | 0.01% | -33.3% |
| Q4 2020 | $68,985,000 | – | 1,434,796 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 3,743,875 | $103,181,000 | 7.44% |
| BVF INC/IL | 6,661,503 | $183,591,000 | 7.16% |
| VR Adviser, LLC | 1,536,193 | $42,337,000 | 5.44% |
| Cormorant Asset Management, LP | 3,073,485 | $84,705,000 | 3.44% |
| GREAT POINT PARTNERS LLC | 329,086 | $9,070,000 | 2.11% |
| Vivo Capital, LLC | 1,238,575 | $34,135,000 | 1.53% |
| ACUTA CAPITAL PARTNERS, LLC | 150,500 | $4,148,000 | 1.46% |
| Foresite Capital Management IV, LLC | 342,030 | $9,426,000 | 1.39% |
| RA Capital Management | 2,150,404 | $59,265,000 | 0.82% |
| SECTORAL ASSET MANAGEMENT INC | 338,381 | $9,326,000 | 0.78% |